New CEO on Board at Rhythmlink

Rhythmlink International has welcomed Paul Buckman as its new CEO and board member.
 
Buckman has more than three decades of experience in the medical device and life sciences sectors, fulfilling senior leadership roles at St. Jude Medical, Pathway Medical Technologies, and LivaNova PLC. 

Rhythmlink Co-Founder Shawn Regan is now board chairman; he will provide strategic guidance and mentorship to the organization, and continue to be a significant investor. Regan’s commitment and leadership have been key to Rhythmlink’s growth and success over the past 22 years, according to his fellow executives. 
 
“I’m delighted with my new role and looking forward to working with Paul as this change in leadership marks an exciting new chapter for Rhythmlink,” Regan said. “Under Paul’s guidance as CEO, we will continue to build upon our existing strengths in the ever-evolving neurodiagnostic space. The opportunities for Rhythmlink are numerous and I’m excited to see our continued growth while we extend our focus and dedication to providing the highest level of customer service and improving patient care.”
 
Rhythmlink designs and manufactures single-use brain health and neurodiagnostic solutions. Rhythmlink serves the electroencephalography (EEG), intraoperative neuromonitoring (IONM), and electromyography (EMG) end markets through its disposable portfolio of U.S. Food and Drug Administraton-cleared conditional MR EEG electrodes, CT imaging compatible electrodes, subdermal needles, EMG electrodes, and other neurodiagnostic products. Focus areas include workflow efficiencies, labor cost savings, reduction in training time, and lower rates of costly hospital-acquired infections. Headquartered in Columbia, S.C., the company has more than 300 employees and operates a manufacturing and assembly facility. Rhythmlink was acquired last year by Graham Partners, a private investment firm.